2009
DOI: 10.1016/j.jaad.2008.08.048
|View full text |Cite
|
Sign up to set email alerts
|

Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
108
0
11

Year Published

2009
2009
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 101 publications
(124 citation statements)
references
References 28 publications
5
108
0
11
Order By: Relevance
“…23---26 Some studies also used quality-of-life scales (Eczema Disability Index, 17 Sickness Impact Profile 6 ) and assessments of pruritus. 8,14,20,22,27 Cumulative dosage was an outcome measure in 1 study 19 and length of remission was used in 2 studies. 7,21…”
Section: Included Studiesmentioning
confidence: 99%
“…23---26 Some studies also used quality-of-life scales (Eczema Disability Index, 17 Sickness Impact Profile 6 ) and assessments of pruritus. 8,14,20,22,27 Cumulative dosage was an outcome measure in 1 study 19 and length of remission was used in 2 studies. 7,21…”
Section: Included Studiesmentioning
confidence: 99%
“…Akut AD'de kullanımı önerilen bu fototerapi yöntemini, çok daha yaygın olarak kullanılan dar bant UVB ile karşılaştıran çalışmalar da bulunmaktadır. Bu çalışmalardan birinde kronik AD'de dar bant UVB, orta doz UVA1'den daha etkili bulunurken (70), diğer iki çalışmada her iki tedavi yönteminin de eşit etkinliğe sahip oldukları gösterilmiştir (71,72).…”
Section: Atopik Dermatitte Fototerapiunclassified
“…Auffällig war das Sistieren des Pruritus nach nur durchschnittlich 3-4 Sitzungen, das uns in der Form nur von einer UVA1-Therapie geläufig war [22]. Majoie et al [20] räumten erst kürzlich der NUVB-Therapie den gleichen therapeutischen Nutzen wie einer UVA1-Therapie ein. Zwei Studien mit kleinen Kollektiven (.…”
Section: Diskussionunclassified
“…Im Konsensuspapier zur Therapie der ausgeprägten atopischen Dermatitis wurde der Effekt einer 311-nm-UVBPhototherapie als erfolgreich eingestuft [5]. Einige Arbeitsgruppen sehen in einer "Narrow-band-" (311 nm) NUVB sogar therapeutische Vorteile gegenüber einer UVA1-Bestrahlung [20,26]. Wir stellten uns somit die Frage, ob eine gezielte UVB-308-nm-Phototherapie eine erfolgreiche Behandlungsalternative insbesondere für die kleinflächige atopische Dermatitis darstellen könnte.…”
unclassified